Johanna C van Huijstee, Kelsey R van Straalen, Dorra Bouazzi, Cecilia E Medianfar, Gregor B E Jemec, Robin Christensen, Pim Aarts, Raveena A Mangal, Beyza Erdal, Nienke C T Geraedts, Errol P Prens, Hessel H van der Zee
{"title":"荷兰化脓性汗腺炎的患病率：作为全球化脓性汗腺炎地图集（GHiSA）一部分的横断面研究。","authors":"Johanna C van Huijstee, Kelsey R van Straalen, Dorra Bouazzi, Cecilia E Medianfar, Gregor B E Jemec, Robin Christensen, Pim Aarts, Raveena A Mangal, Beyza Erdal, Nienke C T Geraedts, Errol P Prens, Hessel H van der Zee","doi":"10.1159/000542816","DOIUrl":null,"url":null,"abstract":"<p><strong>Introduction: </strong>The global prevalence of the chronic and debilitating skin disease hidradenitis suppurativa (HS) is currently unknown. Depending on the research type and the studied population, reported prevalence rates for HS range from 0.03% to 4.1%. It is crucial to investigate the global prevalence of HS using a standardized study design to facilitate earlier recognition, diagnosis, and treatment of patients. Consequently, a worldwide initiative, the Global Hidradenitis Suppurativa Atlas (GHiSA), has developed a study design to investigate the worldwide prevalence of HS in a comparable manner. In cooperation with this initiative, this study aimed to investigate the prevalence of HS in the Netherlands.</p><p><strong>Methods: </strong>An explorative, descriptive, cross-sectional mono-center study was conducted at the Ear Nose Throat and Internal Medicine department of the Erasmus Medical Center. Healthy adults accompanying patients undergoing care in a hospital setting were asked to fill out a validated questionnaire and undergo physical examination. Primary outcome was the point prevalence of HS.</p><p><strong>Results: </strong>In total, 663 participants were included in this study. Overall, the prevalence of HS was 0.60% (4/663, 95% confidence interval 0.32%-1.54%).</p><p><strong>Conclusion: </strong>The point prevalence of HS in the Netherlands is 0.60%. This study is part of a global initiative; therefore, data can be incorporated in a worldwide analysis of the HS prevalence.</p>","PeriodicalId":11185,"journal":{"name":"Dermatology","volume":" ","pages":"1-6"},"PeriodicalIF":2.7000,"publicationDate":"2025-07-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12233984/pdf/","citationCount":"0","resultStr":"{\"title\":\"Prevalence of Hidradenitis Suppurativa in the Netherlands: A Cross-Sectional Study as Part of the Global Hidradenitis Suppurativa Atlas (GHiSA).\",\"authors\":\"Johanna C van Huijstee, Kelsey R van Straalen, Dorra Bouazzi, Cecilia E Medianfar, Gregor B E Jemec, Robin Christensen, Pim Aarts, Raveena A Mangal, Beyza Erdal, Nienke C T Geraedts, Errol P Prens, Hessel H van der Zee\",\"doi\":\"10.1159/000542816\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><strong>Introduction: </strong>The global prevalence of the chronic and debilitating skin disease hidradenitis suppurativa (HS) is currently unknown. Depending on the research type and the studied population, reported prevalence rates for HS range from 0.03% to 4.1%. It is crucial to investigate the global prevalence of HS using a standardized study design to facilitate earlier recognition, diagnosis, and treatment of patients. Consequently, a worldwide initiative, the Global Hidradenitis Suppurativa Atlas (GHiSA), has developed a study design to investigate the worldwide prevalence of HS in a comparable manner. In cooperation with this initiative, this study aimed to investigate the prevalence of HS in the Netherlands.</p><p><strong>Methods: </strong>An explorative, descriptive, cross-sectional mono-center study was conducted at the Ear Nose Throat and Internal Medicine department of the Erasmus Medical Center. Healthy adults accompanying patients undergoing care in a hospital setting were asked to fill out a validated questionnaire and undergo physical examination. Primary outcome was the point prevalence of HS.</p><p><strong>Results: </strong>In total, 663 participants were included in this study. Overall, the prevalence of HS was 0.60% (4/663, 95% confidence interval 0.32%-1.54%).</p><p><strong>Conclusion: </strong>The point prevalence of HS in the Netherlands is 0.60%. This study is part of a global initiative; therefore, data can be incorporated in a worldwide analysis of the HS prevalence.</p>\",\"PeriodicalId\":11185,\"journal\":{\"name\":\"Dermatology\",\"volume\":\" \",\"pages\":\"1-6\"},\"PeriodicalIF\":2.7000,\"publicationDate\":\"2025-07-07\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12233984/pdf/\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Dermatology\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.1159/000542816\",\"RegionNum\":3,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q2\",\"JCRName\":\"DERMATOLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Dermatology","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1159/000542816","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"DERMATOLOGY","Score":null,"Total":0}
Prevalence of Hidradenitis Suppurativa in the Netherlands: A Cross-Sectional Study as Part of the Global Hidradenitis Suppurativa Atlas (GHiSA).
Introduction: The global prevalence of the chronic and debilitating skin disease hidradenitis suppurativa (HS) is currently unknown. Depending on the research type and the studied population, reported prevalence rates for HS range from 0.03% to 4.1%. It is crucial to investigate the global prevalence of HS using a standardized study design to facilitate earlier recognition, diagnosis, and treatment of patients. Consequently, a worldwide initiative, the Global Hidradenitis Suppurativa Atlas (GHiSA), has developed a study design to investigate the worldwide prevalence of HS in a comparable manner. In cooperation with this initiative, this study aimed to investigate the prevalence of HS in the Netherlands.
Methods: An explorative, descriptive, cross-sectional mono-center study was conducted at the Ear Nose Throat and Internal Medicine department of the Erasmus Medical Center. Healthy adults accompanying patients undergoing care in a hospital setting were asked to fill out a validated questionnaire and undergo physical examination. Primary outcome was the point prevalence of HS.
Results: In total, 663 participants were included in this study. Overall, the prevalence of HS was 0.60% (4/663, 95% confidence interval 0.32%-1.54%).
Conclusion: The point prevalence of HS in the Netherlands is 0.60%. This study is part of a global initiative; therefore, data can be incorporated in a worldwide analysis of the HS prevalence.
期刊介绍：
Published since 1893, ''Dermatology'' provides a worldwide survey of clinical and investigative dermatology. Original papers report clinical and laboratory findings. In order to inform readers of the implications of recent research, editorials and reviews prepared by invited, internationally recognized scientists are regularly featured. In addition to original papers, the journal publishes rapid communications, short communications, and letters to ''Dermatology''. ''Dermatology'' answers the complete information needs of practitioners concerned with progress in research related to skin, clinical dermatology and therapy. The journal enjoys a high scientific reputation with a continually increasing impact factor and an equally high circulation.
求助内容：
应助结果提醒方式：
京公网安备 11010802042870号
